- Exchange: New York
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Generic Drugs
Taro Pharmaceutical Industries Ltd
+ Add to WatchlistTARO:US
63.9700 USD 1.1100 1.77%As of 20:04:03 ET on 05/17/2013.
Snapshot for Taro Pharmaceutical Industries Ltd (TARO)
| Open: | 62.8900 | Day's Range: | 62.8900 - 64.2400 | Volume: | 32,917 |
|---|---|---|---|---|---|
| Previous Close: | 63.9700 | 52wk Range: | 34.8400 - 64.2400 | 1-Yr Rtn: | +55.61% |
Key Statistics for TARO
| Current P/E Ratio (ttm) | 15.4891 |
|---|---|
| Estimated P/E(12/2012) | - |
| Relative P/E vs. SPX | 0.9493 |
| Earnings Per Share (ttm) | 4.1300 |
| Est. EPS (12/2012) | - |
| Est. PEG Ratio | - |
| Market Cap (M USD) | 2,845.13 |
| Shares Outstanding (M) | 44.48 |
| 30 Day Average Volume | 18,531 |
| Price/Book (mrq) | 3.3734 |
| Price/Sale (ttm) | 5.6175 |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 05/23/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for TARO
Company Profile & Key Executives for TARO
Taro Pharmaceutical Industries Ltd. is a multinational, science-based pharmaceutical company that discovers, develops, manufactures, and markets healthcare products. The Company's products include prescription and over-the-counter drugs.
| Kal SundaramChairman | James KedrowskiInterim CEO |
| Michael H KalbInterim CFO/Chief Acctg Ofcr | Hannah BayerGroup VP:Finance |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
TARO News
-
Industry News
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page